文献速递其他结缔组织病

miRNA作为干燥综合征亚临床动脉粥样硬化潜在生物标志物

miRNAs as potential biomarkers for subclinical atherosclerosis in Sjögren's disease.
PubMed 文献 · RMD Open · 2024-08-22

纳入199例干燥综合征患者和100例年龄性别匹配的健康对照,检测5种与内皮功能相关的血清miRNA。结果显示4种miRNA表达差异有统计学意义,miR-92a-3p与颈动脉内膜中层厚度正相关,提示其可能有助于干燥综合征早期动脉粥样硬化的分子检测。

要点

  • 干燥综合征患者血清miR-92a-3p较健康对照上调(p=0.025)。
  • miR-126-3p、miR-143-3p和miR-204-5p在干燥综合征中较健康对照下调。
  • miR-92a-3p水平与颈动脉内膜中层厚度正相关(r=0.148,p=0.04)。

核心结论

  • 干燥综合征患者中与内皮功能调节相关的miRNA表达存在差异,特定miRNA降低与心血管风险增加相关,提示这些miRNA可能具有保护作用。
  • miR-92a-3p可能有助于干燥综合征早期动脉粥样硬化和心血管风险增加的分子检测。

研究设计与样本

  • 研究纳入199例干燥综合征患者和100例年龄、性别匹配的健康对照。
  • 采用定量实时PCR分析5种miRNA(hsa-miR-92a-3p、hsa-miR-126-3p、hsa-miR-143-3p、hsa-miR-145-5p、hsa-miR-204-5p),并将结果与已知临床及疾病相关参数比较。

主要发现

  • 与健康对照相比,干燥综合征患者miR-92a-3p上调(p=0.025)。
  • 与健康对照相比,干燥综合征患者miR-126-3p(p=0.044)、miR-143-3p(p=0.006)和miR-204-5p(p=0.009)下调。
  • 健康对照与伴或不伴器官受累的干燥综合征患者比较,伴器官受累的干燥综合征患者miR-92a-3p水平描述性升高(p=0.087)。
  • miR-92a-3p水平与作为亚临床动脉粥样硬化表现的颈动脉内膜中层厚度正相关(r=0.148,p=0.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: MicroRNAs (miRNAs) can regulate gene expression, controlling numerous cellular processes. Dysregulation of miRNA function is linked to various diseases, making them attractive diagnostic and therapeutic targets. Examples include hsa-miR-92a-3p, hsa-miR-126-3p, hsa-miR-143-3p, hsa-miR-145-5p and hsa-miR-204-5p, which are associated with endothelial function. Their prevalence in Sjögren's disease (SjD) is unknown. We assessed the prevalence of these miRNAs in serum of patients with SjD, correlating levels with cardiovascular risk factors and carotid intima-media thickness (cIMT) to evaluate their utility in risk stratification. METHODS: 199 patients with SjD and 100 age and sex-matched healthy controls (HC) were included in the study. Five different miRNAs (hsa-miR-92a-3p; hsa-miR-126-3p; hsa-miR143-3p; hsa-miR-145-5p; hsa-miR-204-5p) were analysed by quantitative real-time PCR. The miRNA results were compared with known clinical and disease-related parameters. RESULTS: Four miRNAs showed significantly different expressions compared with HC. MiR-92a-3p was upregulated (p=0.025) and miR-126-3p (p=0.044), miR-143-3p (p=0.006) and miR-204-5p (p=0.009) downregulated in SjD compared with HC. The comparison between HC and SjD with/without organ involvement revealed descriptively increased miR-92a-3p levels in patients with SjD with organ involvement (p=0.087). Furthermore, miR-92a-3p levels correlated positively with cIMT as an expression of subclinical atherosclerosis (r=0.148, p=0.04). CONCLUSION: In conclusion, patients with SjD demonstrated differences in their expression of miRNAs linked to regulation of endothelial function. Reduction of specific miRNAs was associated with increased cardiovascular risk, suggesting a potentially protective role for these miRNAs. Furthermore, miR-92a-3p could be helpful for molecular detection of early-stage atherosclerosis and increased cardiovascular risk in SjD.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Zehrfeld N, Abelmann M, Benz S, et al. miRNAs as potential biomarkers for subclinical atherosclerosis in Sjögren's disease. RMD Open. 2024. PMID: 39179256. doi:10.1136/rmdopen-2024-004434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。